Founded in July 2005, Porton Pharma Solutions Ltd. (Stock abbreviation: Porton Share; Stock code: 300363) is a leading pharmaceutical CDMO (Contract Development Manufacture Organization) in China.
From the early stage of development, Porton has provided global pharmaceutical companies and new drug R&D (Research and Development) institutions with customized R&D.